Skip to content

Author

Bo-Wen Cui

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Mechanisms and Clinical Breakthroughs of Bispecific Antibody–Drug Conjugates (BsADCs)- Dual‑Targeting Strategies Exemplified by EGFR/HER3

BsADCs represent a new promising strategy to address tumor heterogeneity, antigen escape, and bypass signaling as well as improve targeted payload delivery and can serve as a theoretical background for designing and testing BsADCs.

Bo-Wen Cui · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.